Healthcare and Life Science
Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security, AI innovation, an...
Daniel Zeichner MP hails Labour’s green light for Cambridge Cancer Hospital
Following the publication of the Labour Government’s review of the New Hospital Programme, funding has today (Monday 20th January) been confirmed and a green light given for Cambridge Cancer Research Hospital. ...
Bio-Rad extends range of Vericheck ddPCR Empty-Full Capsid Kits to optimize AAV Vector Characterization
New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality HERCULES, Calif. — January 21, 2025 — Bio-Rad Laboratories, Inc., a global leader in life science r...
Glox Therapeutics awarded share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosisProgramme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet needGlasgow, ...
Engineering biology to accelerate breakthroughs in human health
Sable&Hawkes have been appointed to work with DNA Script on a new set of customer-orientated messages and branded marketing and communications assets. ...
Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain's fastest-growing private technology companies
Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research servicesCambridge, UK, 20 January 2025: Metrion Bio...
The Cambridge Young Professionals Group (CYPG) releases its memberships for 2025
The CYPG), a group for graduates and young professionals in the Cambridge area, has released its memberships for 2025. ...
CMR Surgical appoints Massimiliano Colella as Chief Executive Officer
Massimiliano Colella appointed CEO at CMR Surgical, leading the company in its mission to bring the benefits of robotic-assisted minimal access surgery to patients around the world with Versius ...
Partnership with Cognidox Ltd
So thrilled to announce this collaboration with Cognidox as part of our joint mission to ensure that business Quality and Systems are running efficiently, along with providing support to easy introduction to ISO certification. Quote from Cognidox ...
DNA damage can last unrepaired for years, changing our view of mutations
While most known types of DNA damage are fixed by our cells’ in-house repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows. This means that the damage has multiple chances to generate harmful mutations, which can lead to cancer. ...